DUBLIN--(BUSINESS WIRE)--
Research and Markets (http://www.researchandmarkets.com/research/d8rspq/global) has announced the addition of the "Global Nanomedicine Market 2012-2016" report to their offering.
The analysts forecast the Global Nanomedicine market to grow at a CAGR of 12.57 percent over the period 2012-2016.
The report, the Global Nanomedicine Market 2012-2016, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market in the Americas, and the EMEA and APAC regions; it also covers the Global Nanomedicine market landscape and its growth prospects in the coming years. The report also includes a discussion of the key vendors operating in this market.
Key questions answered in this report:
- What will the market size be in 2016 and what will be the growth rate?
- What are key market trends?
- What is driving this market?
- What are the challenges to market growth?
- Who are the key vendors in this market space?
See original here:
Research and Markets: Global Nanomedicine Market to 2016 with Abbott, AstraZeneca, BMS, Celgene, GSK, and Pfizer ...